1. Home
  2. EVGN vs SNOA Comparison

EVGN vs SNOA Comparison

Compare EVGN & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evogene Ltd

EVGN

Evogene Ltd

N/A

Current Price

$0.28

Market Cap

5.1M

Sector

Industrials

ML Signal

N/A

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

N/A

Current Price

$1.11

Market Cap

5.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVGN
SNOA
Founded
1999
1999
Country
Israel
United States
Employees
N/A
260
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.1M
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
EVGN
SNOA
Price
$0.28
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 39.2K
37.4K
Earning Date
11-19-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.26
EPS
★ N/A
N/A
Revenue
N/A
★ $19,529,000.00
Revenue This Year
N/A
$22.44
Revenue Next Year
$81.06
$12.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.68
52 Week Low
$0.35
$0.85
52 Week High
$1.28
$3.95

Technical Indicators

Market Signals
Indicator
EVGN
SNOA
Relative Strength Index (RSI) 21.66 46.03
Support Level N/A $1.03
Resistance Level $0.41 $1.29
Average True Range (ATR) 0.02 0.07
MACD -0.00 0.00
Stochastic Oscillator 7.95 50.00

Price Performance

Historical Comparison
EVGN
SNOA

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: